Dr. Louis Sang-Soo Park, MD

Dr. Park practices at CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems.

Dr. Park's NPI, 1962446039, was assigned on June 16, 2006. Dr. Park graduated from Keck School of Medicine of USC in 1992. Dr. Park holds California license G79245.

Dr. Park's primary practice is CHA Hollywood Presbyterian Medical Center, at 1300 N Vermont Ave, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (213) 413-3000.

Dr. Park's primary practice is CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems. Dr. Park is also affiliated with PIH Health Good Samaritan Hospital. Dmand AI also links Dr. Park to 1 more hospital, 1 breast imaging center, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Park is licensed in California.

Dmand AI lists asthma, chest trauma, chronic obstructive pulmonary disease (COPD), lung disease: COPD, asthma or bronchitis, pneumonia and respiratory infection and pulmonary fibrosis among the conditions Dr. Park treats.

CMS data shows 3,527 Medicare services from Dr. Park across 6 procedure codes in 2024, for 403 Medicare patients. Medicare paid $321,632 for them.

CMS counts 403 Medicare patients who saw Dr. Park in 2024. The largest group is 85 and over, with 195 patients. 75% of them have arthritis, and 75% have high blood pressure. 95% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 79, with 51% women.

In 2024, Dr. Park wrote 1,573 Medicare Part D claims for 586 patients. 81% of them were for generic drugs. CMS names the drug for 1,247 of them, across 35 drugs with 11 or more claims each, at $88,694 in total drug cost. In 2023, CMS named 1,109 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Park for performance year 2024, reported individually. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Park, published from 2022 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Anticoagulants, Hemorrhage and Myocardial Infarction. Dr. Park's most frequent co-author is Michael Wang, MD.

CMS Open Payments shows 57 general payments to Dr. Park from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sanofi and Genzyme US Companies paid the most, $607.

Dr. Park graduated from Keck School of Medicine of USC in 1992.

Dr. Park is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.